Report on Our Company (Additional Explanation Regarding “Sumitomo Chemical and Sumitomo Pharmaceutical: The ¥116 Billion Swiss Shuffle”)
Sumitomo Pharma Co.,Ltd. (a consolidated subsidiary of SUMITOMO CHEMICAL COMPANY,LIMITED) and the Sumitomo Chemical Group
Assets related to North American subsidiaries, the Asia business, Sumitomo Pharma Switzerland GmbH (SMPS), and 3 key US products, among others
Gotham City Research LLC (GCR) published a report dated 3 August 2026 concerning our Company and our Group
A ¥49.0 billion gain on the transfer of investments in affiliates was recognized in consolidated results for the fiscal year ended March 2026. Of the total ¥164.5 billion in dividends from SMPS, ¥116.2 billion was deducted from the carrying value of the shares held and ¥48.3 billion was recognized as dividend income
Fiscal year ended March 2026 (amounts already recognized and covered by the explanation)
The Company will work to ensure the reliability and transparency of its financial reporting and provide investors with timely and appropriate disclosures. It will take appropriate action, including legal measures where necessary, in response to inaccurate or misleading information
| Item | Details |
|---|---|
| Event name | Report on Our Company (Additional Explanation Regarding “Sumitomo Chemical and Sumitomo Pharmaceutical: The ¥116 Billion Swiss Shuffle”) |
| Date of occurrence | 3 August 2026 (date the GCR report was published); 7 August 2026 (date the additional explanation was published) |
| Subject Entity | Sumitomo Pharma Co.,Ltd. (a consolidated subsidiary of SUMITOMO CHEMICAL COMPANY,LIMITED) and the Sumitomo Chemical Group |
| Target Locations / Products | Assets related to North American subsidiaries, the Asia business, Sumitomo Pharma Switzerland GmbH (SMPS), and 3 key US products, among others |
| Cause | Gotham City Research LLC (GCR) published a report dated 3 August 2026 concerning our Company and our Group |
| Amount of Impact on Business Performance | A ¥49.0 billion gain on the transfer of investments in affiliates was recognized in consolidated results for the fiscal year ended March 2026. Of the total ¥164.5 billion in dividends from SMPS, ¥116.2 billion was deducted from the carrying value of the shares held and ¥48.3 billion was recognized as dividend income |
| Accounting period in which recognized | Fiscal year ended March 2026 (amounts already recognized and covered by the explanation) |
| Outlook | The Company will work to ensure the reliability and transparency of its financial reporting and provide investors with timely and appropriate disclosures. It will take appropriate action, including legal measures where necessary, in response to inaccurate or misleading information |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To explain its views and the basis for those views regarding the report’s principal claims, having taken seriously the potential impact on investors’ decision-making of the report published by Gotham City Research on 3 August 2026.